Aenitis Technologies
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
53 1,172Activities
Technologies
Entity types
Location
16 Rue de la Grange aux Belles, 75010 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 16
SIREN
886349125Engaged corporates
21
5 17Added in Motherbase
6Â years ago
deeptech Value proposition
Acoustic Cell Processing Solution
🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use.
đź’ˇToday, we have achieved proof-of-concepts for our contact-free & label-free proprietary technology across multiple cell types & processes. MitisTM, our flagship product, is already used for a wide range of applications, including cell sorting, isolation, concentration & washing, from research to clinical and industrial scale.
🌍Co-founded by pioneers of acoustic levitation & fluid mechanics and a biotech entrepreneur, the company benefits from the support of the European Commission & the French Government and from the commitment of leading investors, notably the European Investment Bank and Seventure Partners.
Sorting, acoustophoresis, medical devices, cells, and BioproductionOriginal language
Acoustic Cell Processing Solution
🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use.
đź’ˇToday, we have achieved proof-of-concepts for our contact-free & label-free proprietary technology across multiple cell types & processes. MitisTM, our flagship product, is already used for a wide range of applications, including cell sorting, isolation, concentration & washing, from research to clinical and industrial scale.
🌍Co-founded by pioneers of acoustic levitation & fluid mechanics and a biotech entrepreneur, the company benefits from the support of the European Commission & the French Government and from the commitment of leading investors, notably the European Investment Bank and Seventure Partners.
Accueil - Aenitis
Aenitis, a pioneer in acoustic-based cell manipulation, revolutionizes bioproduction with its non-invasive, scalable acoustofluidic technology, enabling
https://www.aenitis.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Avolta Finance, Investment Banking | Avolta Finance, Investment Banking | Other 18 Oct 2024 | | |
 | Gouvernement | Other 30 Sep 2021 | | |
 | Ministère de la Santé | Other 30 Sep 2021 | | |
 Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Other 30 Sep 2021 | | |
 Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 31 Mar 2022 | | |
 Eurofins Scientifique Biotechnology, Biotechnology Research | Eurofins Scientifique Biotechnology, Biotechnology Research | Other 31 Mar 2022 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 31 Mar 2022 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 5 Oct 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 28 Feb 2022 | | |
 Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 12 Oct 2024 | | |